Wolfe Research confirms the “Outperform” test for the Unitedhealth Group (UNH) in the middle of the medical billing pressure

Unitedhealth Group Incorporated (NYSE:UNH) Is One of the top shares of Goldman Sachs' Top Health. On July 10th, Wolfe Research repeated an “outperform” rating for the share. However, the research company reduced its price target from 363 US dollars to 330 US dollars, citing medical billing printing, which the company is exposed.

A hospital technician who uses a laptop to check a patient's health plans in the ward.

Since then, the research company has revised the company's profit estimate in 2025 to $ 18. The revision underlines a more conservative view, since Unitedhealth is exposed to the pressure of the industries in medicaid and health insurance. The research company sees Optum Health and Medicare Advantage as units with considerable profit pressure.

According to Wolfe Research, Unitedhealth creates 1% margins in the mediocre advantage, which is among his long -term margins. The company is expected to update its profit guidelines from 2025 and in the middle of the pressure by the billing of health insurance illuminating information about its violation of profits.

The UnitedHealth Group Incorporated (NYSE: UNH) is a healthcare company that offers consumer-oriented plans and services for health services. It also offers patients care, care management, wellness and consumers as well as health financial services for patients.

While we acknowledge the potential of UNH as an investment, we believe that certain AI shares offer higher upward potential and form a less downward risk. If you are looking for an extremely undervalued AI population that also benefits significantly from tariffs from the Trump era and the onshoring trend, you will find our free report on the Best short-term AI.

Read next: 11 Best Green Energy Penny Stocks to buy now And 10 most popular Ki -Penny shares that can buy after billionaires.

Disclosure: none. This article is originally published at Insider Monkey.